HIV-1 Infection Impairs CD16 and CD35 Mediated Opsonophagocytosis of Mycobacterium tuberculosis by Human Neutrophils by Bangani, N et al.
BRIEF REPORT: BASIC AND TRANSLATIONAL SCIENCE
HIV-1 Infection Impairs CD16 and CD35 Mediated
Opsonophagocytosis ofMycobacterium tuberculosis
by Human Neutrophils
Nonzwakazi Bangani, BSc,* Justine Nakiwala, BSc,*†‡ Adrian R. Martineau, PhD,§k¶
Robert J. Wilkinson, PhD,*k¶ Katalin A. Wilkinson, PhD,*¶ and David M. Lowe, PhD*k#
Abstract: Using a ﬂow cytometric assay, we investigated
neutrophil–Mycobacterium tuberculosis opsonophagocytosis and
the impact of HIV-1–infected serum on this process. The mean
(6SD) percentage of neutrophils internalizing bacilli after 30 mi-
nutes incubation was signiﬁcantly reduced by pretreatment with
anti-CD16 (18.2% 6 8.1%, P , 0.001) or anti-CD35 antibody
(23.2% 6 10.6%, P , 0.05) versus anti-CD4 controls (29.9% 6
8.1%). Blocking CD88 or CD11a did not affect internalization.
Using heat-inactivated serum, maximal internalization was
lower using HIV-1–infected serum versus HIV-1–uninfected.
Using non–heat-inactivated serum, internalization decreased more
rapidly with sequential dilutions of HIV-1–infected versus HIV-1–
uninfected serum. CD16 and CD35 are important for neutrophil
internalization of M. tuberculosis, whereas HIV-1 infection
adversely affects opsonophagocytosis.
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BACKGROUND
The host immune response to tuberculosis remains
incompletely understood, but neutrophils are increasingly rec-
ognized as having important protective and pathogenic roles.1–3
Neutrophils are professional phagocytes which inter-
nalize mycobacteria to kill them,2 trafﬁc them to distant sites,4
or act as immunologically privileged sites allowing bacillary
survival or replication.5,6 Phagocytosis by neutrophils is
improved by opsonization, as has been speciﬁcally demon-
strated for M. tuberculosis.7
We therefore sought to interrogate the biology behind
opsonization and phagocytosis of M. tuberculosis by human
neutrophils. First, we investigated which cell surface
receptors are important for mediating internalization, focus-
ing on complement receptors (CRs) and Fc-g receptors that
mediate macrophage phagocytosis of tuberculosis bacilli.8
Subsequently, to address a clinically relevant question, we
compared the opsonization capacity of serum from HIV-1–
infected and HIV-1–uninfected persons.
METHODS
Serum Donors and Preparation
For receptor-blocking experiments, serum was prepared
from 21 consenting healthy laboratory donors using SST tubes
(Becton Dickinson, South Africa), pooled and stored at 280°
C. For comparison of serum depending on HIV-1 status,
asymptomatic antiretroviral therapy–naive HIV-1–infected
persons with CD4 count ,350 · 106/mL were recruited from
the Ubuntu HIV clinic, Khayelitsha, South Africa. The HIV-
1–uninfected cohort was recruited from the Ubuntu clinic or
Khayelitsha Site B Youth Centre among asymptomatic
individuals with a recent negative HIV test. HIV testing, viral
load, and CD4 count were performed by the South African
National Health Laboratory Service. To generate serum, fresh
blood was centrifuged at 500g in 15 mL Falcon tubes for
15 minutes before transferring plasma to a new tube in a water
bath at 37°C; after platelets had plugged serum was aspirated
and stored at 280°C. Donors provided written, informed
consent. The study protocol was approved by the University
of Cape Town Research Ethics Committee (HREC 545/2010).
Heat inactivation was performed in a water bath at 56°C
for 30 minutes.
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Isolation of Human Neutrophils
This has been described previously.9 Brieﬂy, 25 mL
blood from healthy laboratory donors were sedimented using
6% dextran, the cell-rich supernatant was suspended in 3 mL
55% Percoll and layered onto a discontinuous gradient of 81%
Percoll and 70% Percoll. Tubes were centrifuged at 720g with
no deceleration and granulocytes harvested from the 81%/70%
interface before Coulter counting.
Organisms and Labeling
1.5 mL vials of M. tuberculosis-lux (prepared as
described9) were defrosted from storage at 280°C and added
to 15 mL 7H9/ADC (Becton Dickinson) containing 0.05%
Tween 80 (Sigma) and 1 mcl/mL hygromycin B (Roche).
Organisms were cultured before use to mid-log phase (72
hours). Fluorescein isothiocyanate (FITC) labeling was per-
formed as described on 5 mL of organism culture9; mycobac-
teria were resuspended in 7H9 medium and then diluted with
phosphate-buffered saline to reach the desired inoculum
immediately before infection.
Phagocytosis Assay
This assay has been described in detail.9 During
receptor-blocking experiments, the methodology was applied
as published, ie, 50 mcl of serum (10% ﬁnal concentration)
and 50 mcl of FITC-labeled M. tuberculosis at multiplicity of
infection (MOI) 1 Colony Forming Unit (CFU): 3 neutrophils
were added to 400 mcl of neutrophils suspended in RPMI-
1640 at a concentration of 1 · 106/mL.
For experiments comparing serum opsonic capacity, the
methodology was modiﬁed to resemble opsonophagocytosis
assays developed for Streptococcus pneumoniae.10 Serum was
serially diluted 1:1 with RPMI-1640 during preparation. Neu-
trophils were resuspended at 2 · 106/mL, and 200 mcl of this
suspension were added to tubes together with 250 mcl prediluted
serum and 50 mcl organisms. This modiﬁcation allowed
a maximum serum concentration of 50%, although preliminary
experiments indicated maximal internalization at 25% ﬁnal
serum concentration (reported herein as “1 in 4”). The next
dilution assessed was 1 in 8 for heat-inactivated serum and 1 in
32 for non–heat-inactivated serum (preliminary experiments
indicated little reduction in internalization at concentrations
between 1 in 8 and 1 in 32 for non–heat-inactivated serum).
Dilutions then proceeded 2-fold. To ensure adequate internaliza-
tion even with heat-inactivated serum, a higher MOI was used of
3 CFU: 1 neutrophil. Each pairwise comparison of an HIV-1–
infected and HIV-1–uninfected serum used a single donor’s
neutrophils. In addition to the percentage of neutrophils internal-
izing organisms at each serum concentration, we also calculated
a “breakpoint,” the concentration at which internalization fell to
less than 50% of that seen at maximum concentration. If 50% of
maximum internalization was not reached, then the breakpoint
was deﬁned as a 2-fold further dilution than the last dilution
tested. We also repeated the analysis excluding those samples
which failed to reach breakpoint.
After samples were prepared, they were incubated for
30 minutes on rocking plates at 37°C and then processed at 0°C
as described.9 The ﬂow cytometric analysis is summarized in
Figure 1A. Results are presented as total percentage of CD66+
neutrophils positive for FITC signal.
Blocking Antibodies
Neutrophils were incubated on ice with azide-free
antibodies for 30 minutes before the addition of serum and
mycobacteria (volumes determined by preliminary titration
experiments): 10 mcl anti-CD4 (control), 0.5 mcl anti-CD11a,
10 mcl anti-CD16, 10 mcl anti-CD35, and 0.5 mcl anti-CD88
(all from Becton Dickinson).
Statistical Analysis
Two groups were compared using Student’s t test, 3 or
more groups were analyzed by 1-way analysis of variance.
Statistical analysis was performed using GraphPad Prism
v4.0 or later.
RESULTS
CD35 and CD16 Are Important for
Internalization of M. tuberculosis
by Neutrophils
Preincubation of neutrophils from 9 donors with anti-
CD35 or anti-CD16 antibodies reduced internalization of
FITC-labeled M. tuberculosis versus anti-CD4 controls in
the presence of pooled healthy donor serum (Fig. 1B). The
mean 6 SD percentage of neutrophils internalizing myco-
bacteria after 30 minutes incubation was 18.2%6 8.1% with
anti-CD16 antibody (P , 0.001) and 23.2% 6 10.6% with
anti-CD35 antibody (P = 0.01) versus 29.9% 6 8.1% in
anti-CD4 controls. Incubation with anti-CD11a had no effect
(28.9% 6 9.2%). Incubation with antibodies against all
receptors suggested a cumulative effect of CD16 and CD35,
with a mean 6 SD percentage neutrophils internalizing of
13.3 6 5.4% (P , 0.001 versus controls; Fig. 1B).
Blockade of CD11a or CD88 Does Not Affect
Internalization of M. tuberculosis
by Neutrophils
Preincubation of neutrophils from 8 donors with anti-
CD11a or anti-CD88 antibodies, singly or in combination, did
not affect internalization of FITC-labeled M. tuberculosis
versus anti-CD4 controls (Fig. 1C). The mean 6 SD
percentage of neutrophils internalizing mycobacteria was
26.0% 6 9.3% with anti-CD11a antibody, 27.25% 6 8.1%
with anti-CD88 antibody, 23.6% 6 10.3% with both anti-
bodies, and 27.0% 6 6.8% in controls (P $ 0.18 for all
comparisons). In preliminary experiments, there was no effect
on phagocytosis even of higher concentrations of these anti-
bodies (anti-CD11a up to 5 mL and anti-CD88 up to 10 mL).
The Opsonic Capacity of Serum From
HIV-1–Infected Persons is Inferior to that of
HIV-1–Uninfected Persons
The results above suggest a role for both complement (by
CD35) and antibodies (by CD16) in mediating neutrophil
phagocytosis of M. tuberculosis. To investigate the impact of
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HIV-1 infection on the activity of these serum opsonins, we
serially diluted heat-inactivated and non–heat-inactivated serum
from 8 antiretroviral-naive HIV-1–infected and HIV-1–unin-
fected donors for use in the phagocytosis assay. Supplemental
Table 1 provides donor demographic details (see Supplemental
Digital Content, http://links.lww.com/QAI/A846).
Results using heat-inactivated samples revealed reduced
internalization with HIV-1–infected persons’ serum at higher
concentrations (mean 6 SD percentage of neutrophils internal-
izing with HIV-1 serum at ﬁnal concentration 1 in 4: 16.7% 6
13.7% versus non–HIV-1 serum, 32.6%6 22.6%, P = 0.048; at
concentration 1 in 8: 14.6%6 10.8% versus non–HIV-1 serum,
31.6% 6 21.8%, P = 0.011; Fig. 2A). At lower serum
concentrations, there was relatively little internalization and no
signiﬁcant differences between HIV-1–infected and HIV-1–
uninfected donors. There was also no difference in “break-
points” between the 2 groups (Fig. 2C). Of note, maximal
internalization in patients with positive interferon gamma release
assay results (n = 6) was higher than in those with negative (n =
9) results (36.1% 6 17.5% versus 15.4% 6 18.0%, P = 0.046).
For non–heat-inactivated serum, there was no differ-
ence in maximal internalization, but at further dilutions of
serum the mean 6 SD percentage of neutrophils internalizing
organisms was signiﬁcantly reduced using HIV-1–infected
patients’ serum (at ﬁnal concentration 1 in 32: 40.9% 6
37.0% versus non–HIV-1 serum, 77.0% 6 13.7%, P = 0.016;
at concentration 1 in 64: 31.5 6 37.0% versus 72.3% 6
14.0%, P = 0.010; at concentration 1 in 128: 24.7% 6 30.8%
versus 65.1% 6 16.9%, P = 0.009; Fig. 2B). Beyond these
concentrations, there was no difference between the 2 groups
(although we were unable to assess all donors at these
concentrations). Correspondingly, the “breakpoints” in the
HIV-1–infected group were seen at signiﬁcantly higher
concentration (mean 6 SD for HIV-infected 1 in 120 6
113 versus HIV-uninfected 1 in 384 6 274, P = 0.048; Fig.
2C). There remained a signiﬁcant difference after excluding 2
samples which did not reach breakpoint: mean 6 SD for
HIV-infected 1 in 120 6 113 versus HIV-uninfected 1 in
299 6 105, P = 0.026.
DISCUSSION
There is a critical role for neutrophils in the host
response to tuberculosis. They are likely to be protective
FIGURE 1. The effect of blocking neutrophil surface receptors on the phagocytosis of M. tuberculosis. A, Representative plot of flow
cytometry analysis. First, singlet signals are gated by Forward Scatter (FSC)-Area (A) versus Height (H). Next, dead cells are excluded with
the eFluor450 Viability Dye (Pacific Blue channel). Neutrophils are gated through high CD66a,c,e-PE expression and finally the per-
centage of neutrophils positive for FITC-labeled M. tuberculosis signal is calculated. B, 4 · 105 neutrophils isolated from healthy donors
(n = 9) were incubated on ice for 30 minutes with antibodies against the receptor(s) indicated before the addition of 10% pooled donor
serum and FITC-labeled M. tuberculosis-lux at MOI 1 CFU: 3 neutrophils. After 30 minutes incubation, samples were processed at 0˚C,
stained with eFluor450 Viability Dye and CD66a,c,e-PE and extracellular fluorescence quenched with trypan blue. The y-axis depicts the
percentage of viable CD66a,c,e-positive neutrophils, which had internalized organisms (positive for FITC signal). Lines represent mean. C,
Samples from 8 healthy donors were processed as in (B) using antibodies against the receptors indicated. Data expressed as in (B). *P,
0.05, ***P , 0.001 (repeated measures 1-way analysis of variance for individual receptor-blocking conditions, post hoc Bonferroni
correction comparing each neutrophil receptor antibody with anti-CD4 control; paired t test of “all” condition versus CD4 controls).
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against initial infection,1–3 which may be of special impor-
tance in people with compromised acquired immune re-
sponses such as in HIV-1 infection, but may play
a detrimental role in active disease.3,5 Nevertheless, it is
clear that many bacilli are inside neutrophils during human
tuberculosis infection,6 and it is therefore important to study
their internalization.
Here, we have ﬁrst conﬁrmed our own9 and others’7
ﬁndings that complement is a critical mediator of neutrophil–
M. tuberculosis opsonophagocytosis, demonstrated by a signif-
icant reduction in the percentage of neutrophils phagocytosing
bacilli with heat inactivation of serum. Correspondingly,
blocking CD35 (CR-1) before phagocytosis signiﬁcantly
reduced internalization. By contrast, the C5a receptor CD88
did not seem to play a signiﬁcant role and nor does CD11a
seem to be important in the opsonophagocytosis process.
Despite this apparently major role for complement, we
saw the greatest reduction in phagocytosis with blockade of
CD16 (Fcg-Receptor Receptor IIIb). This may represent
a previously described phenomenon whereby CD16 ligation
is required for subsequent CR3 binding.11 However, it may
also suggest an independent role for antibodies. Even using
heat-inactivated serum we discovered that, with high MOI
and 25% serum concentration, 32.6% 6 22.6% of neutrophils
from HIV-1–uninfected donors were positive for FITC signal.
There was also higher maximal internalization in participants
with evidence of sensitization to M. tuberculosis (positive
interferon gamma release assay result, although this may be
confounded by HIV status). We have previously demon-
strated modest neutrophil phagocytosis of Mycobacterium
bovis Bacille Calmette-Guerin (BCG) with 10% heat-
inactivated adult human serum but a complete absence of
internalization with heat-inactivated fetal calf serum, which
presumably lacks antimycobacterial antibodies.9 This corre-
sponds with ﬁndings by others, for example greater neutrophil
internalization in the presence of heat-inactivated serum
versus no serum7 and increased internalization of M. bovis
BCG in donor samples after BCG vaccination (presumably
due to antibody production).12
Having demonstrated that serum opsonins enhance
neutrophil–M. tuberculosis opsonophagocytosis, we assessed
the opsonic capacity of serum from antiretroviral therapy–
naive HIV-1–infected and HIV-1–uninfected individuals. Op-
sonophagocytosis for Candida albicans and S. pneumoniae is
impaired by HIV-1 infection,13,14 and we here extend that
conclusion to M. tuberculosis. Using heat-inactivated serum,
FIGURE 2. The effect of HIV on the opsonizing capacity of serum for neutrophil phagocytosis of M. tuberculosis. A, Heat-
inactivated serum from HIV-infected donors (white columns) and HIV-uninfected donors (black columns) was serially diluted 2-
fold with RPMI-1640 before adding 250 mL of each concentration to 4 · 105 healthy donor neutrophils and FITC-labeled M.
tuberculosis-lux at MOI 3 CFU: 1 neutrophil. The final serum concentration is depicted on the x-axis. After 30 minutes incu-
bation, samples were processed at 0˚C, stained with Viability Dye and CD66a,c,e-PE and extracellular fluorescence quenched
with trypan blue. The y-axis depicts the percentage of viable CD66a,c,e-positive neutrophils which had internalized organisms
(positive for FITC signal). Each experiment used a single donor’s neutrophils and compared 1 HIV-infected with 1 HIV-unin-
fected serum sample. n = 8, overall (n = 7 for 1/8 dilution), column heights represent mean, error bars represent SD. B, Non–
heat-inactivated samples from the same donors were processed as in (A). n = 8 overall (n = 7 for 1/256 dilution, n = 6 for 1/512
dilution). Data presented as in (A). C, “Breakpoints” were defined from the results of (A) and (B) as the reciprocal of the serum
dilution at which internalization fell to 50% of maximum and are presented for each serum donor/condition. *P , 0.05, **P ,
0.01, ***P , 0.001 (paired t tests).
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we observed a reduction in maximal internalization. For non–
heat-inactivated serum, there was an earlier reduction in
phagocytosis with serial dilution and earlier “breakpoints,”
suggesting global impairment of M. tuberculosis opsonization.
This may relate to ineffective antibody responses.15 Alterna-
tively, we postulate that the polyclonal hypergammaglobuline-
mia characteristic of HIV-1 infection may interfere with
effective opsonophagocytosis. Interestingly, high doses of
IgG administered therapeutically may act through CD16 to
reduce CR3 expression.16 Indeed, we noted in preliminary
experiments that incubation with 50% serum yielded consis-
tently lower internalization than with 25% serum whether heat-
inactivated or not (n = 3 for both groups, statistically signiﬁcant
reduction in non–heat-inactivated group).
An omission from our receptor-blocking experiments
may be CD11b/CD18 (CR3), which could underpin our
inability to fully explain the apparent effect of complement.
Some experiments were performed with a higher CFU:
neutrophil MOI to ensure signiﬁcant internalization with
heat-inactivated serum. As described, there are potential
issues with this approach9 including “clumping” of organ-
isms. However, these experiments represented direct com-
parisons between 1 HIV-1–infected and 1 non–HIV-1–
infected serum sample with other conditions standardized
(including donor neutrophils and infecting inoculum) which
should have avoided systematic bias.
In conclusion, we have delineated some of the critical
mediators of opsonophagocytosis of M. tuberculosis by human
neutrophils and demonstrated an impairment of this process by
HIV-1 infection. These ﬁndings may inform therapeutic
interventions. First, our results demonstrate that HIV-1 infection
compromises an early line of defense against tuberculosis; this
supports prompt initiation of antiretroviral therapy. Conversely,
if neutrophils contribute to pathology in established tuberculosis
disease, especially with a “Trojan horse” role,4,6 then strategies
to block internalization of bacilli should be considered: CD16 or
CD35 would be appropriate targets.
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